Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Peak Bio, Inc./ 10-Q

Quarterly Report · 10-Q

Peak Bio, Inc.

Quarterly Report

Filed Nov 12, 2024Accepted Nov 12, 2024, 4:23 AM ESTCIK 1834645Accession 0000950170-24-124737
View company →Permanent SEC source ↗
Share

Company context

Historical securities (7)
IGNYNASDAQ · EQUITY · Historical · closed Nov 2, 2022IGNYUNASDAQ · UNIT · Historical · closed Nov 1, 2022IGNYWNASDAQ · WARRANT · Historical · closed Nov 1, 2022PKBONASDAQ · EQUITY · Historical · closed Jan 8, 2023PKBOOTC · EQUITY · Historical · closed Nov 14, 2024PKBOWNASDAQ · WARRANT · Historical · closed Jan 8, 2023PKBOWOTC · WARRANT · Historical · closed Nov 13, 2024

Recent company filings

  1. SC 13G/A filingDec 4, 2024
  2. 4 filingDec 4, 2024
  3. EFFECT filingNov 15, 2024
  4. 15-12G filingNov 15, 2024
  5. POS AM filingNov 14, 2024

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗